Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more
Nureca Limited (NURECA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.022x
Based on the latest financial reports, Nureca Limited (NURECA) has a cash flow conversion efficiency ratio of 0.022x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹44.46 Million) by net assets (₹1.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nureca Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Nureca Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nureca Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nureca Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Equites Property Fund Ltd
JSE:EQU
|
0.035x |
|
Profusa, Inc. Common Stock
NASDAQ:PFSA
|
0.313x |
|
PARKER-HANNIFIN CO. - Dusseldorf Stock Exchang
DU:PAR
|
0.058x |
|
Bolt Biotherapeutics
NASDAQ:BOLT
|
-0.303x |
|
Lipum AB
ST:LIPUM
|
1.465x |
|
PIONEER MEDIA HOLDINGS
F:6NU
|
N/A |
|
Noble Helium Ltd
AU:NHE
|
-0.026x |
|
Levinstein Eng
TA:LEVI
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Nureca Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Nureca Limited from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹1.94 Billion | ₹-190.83 Million | -0.098x | -599.40% |
| 2024-03-31 | ₹1.93 Billion | ₹-27.12 Million | -0.014x | -126.76% |
| 2023-03-31 | ₹1.95 Billion | ₹102.27 Million | 0.052x | +662.22% |
| 2022-03-31 | ₹2.03 Billion | ₹13.99 Million | 0.007x | -96.78% |
| 2021-03-31 | ₹1.63 Billion | ₹348.67 Million | 0.214x | +140.30% |
| 2020-03-31 | ₹149.34 Million | ₹-79.23 Million | -0.531x | -1581.51% |
| 2019-03-31 | ₹85.45 Million | ₹3.06 Million | 0.036x | -37.78% |
| 2018-03-31 | ₹17.20 Million | ₹990.00K | 0.058x | +106.30% |
| 2017-03-31 | ₹102.45K | ₹-93.62K | -0.914x | -- |